Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin
Status:
Terminated
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
This study is designed to test two separate strategies for treatment of anemia (low
hemoglobin) and neutropenia (low white blood cells) in HIV/HCV coinfected patients who are
being treated with pegylated interferon and ribavirin.